Thrivent Financial for Lutherans
PGNX

Thrivent Financial for Lutherans’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Thrivent Financial for Lutherans’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-72,429
Closed -$275K – 2327
2020
Q1 		$275K Buy
72,429
+3,616
+5% +$15.6K ﹤0.01% 2020
2019
Q4 		$350K Buy
68,813
+911
+1% +$4.82K ﹤0.01% 2017
2019
Q3 		$343K Buy
67,902
+1,576
+2% +$7.86K ﹤0.01% 1990
2019
Q2 		$409K Buy
66,326
+1,838
+3% +$8.86K ﹤0.01% 1923
2019
Q1 		$299K Buy
64,488
+5,119
+9% +$23.2K ﹤0.01% 2003
2018
Q4 		$249K Buy
59,369
+1,305
+2% +$6.64K ﹤0.01% 1869
2018
Q3 		$364K Buy
58,064
+7,493
+15% +$57.6K ﹤0.01% 1816
2018
Q2 		$407K Buy
50,571
+4,599
+10% +$35.1K ﹤0.01% 1789
2018
Q1 		$343K Buy
45,972
+2,709
+6% +$18K ﹤0.01% 1815
2017
Q4 		$257K Buy
43,263
+853
+2% +$5.18K ﹤0.01% 1931
2017
Q3 		$312K Buy
42,410
+30
+0.1% +$191 ﹤0.01% 1774
2017
Q2 		$288K Buy
42,380
+2,710
+7% +$20K ﹤0.01% 1766
2017
Q1 		$374K Buy
+39,670
New +$396K ﹤0.01% 1666
2016
Q2 		– Sell
-103,280
Closed -$450K – 2051
2016
Q1 		$450K Hold
103,280
– – ﹤0.01% 1414
2015
Q4 		$633K Buy
+103,280
New +$677K ﹤0.01% 1242

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

Thrivent Financial for Lutherans's PGNX Position: Q2 2020 in Review

Thrivent Financial for Lutherans sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 72,429 shares — an estimated $275K sold.

Thrivent Financial for Lutherans first reported a position in PGNX in Q4 2015 and held it in 15 quarters. The position peaked at $633K in Q4 2015. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Thrivent Financial for Lutherans reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 72,429 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $275K.
  • Thrivent Financial for Lutherans first reported a position in Progenics Pharmaceuticals Inc in Q4 2015 and held it in 15 quarters.
  • Thrivent Financial for Lutherans's Progenics Pharmaceuticals Inc position peaked at $633K in Q4 2015.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2020, filed 12 Aug 2020.